¼ºñ½º »óǰ
¸®¼Ä¡ Á¤º¸
°í°´¼¾ÅÍ
°øÁö»çÇ×
´Ù¿î·Îµå
Financial
Information
e-Bond
Revolution
Market
Transparency
BONDWEB ½Ã½ºÅÛÀº ²÷ÀÓ¾ø´Â Á¤º¸Çõ½ÅÀ» ÅëÇØ ±ÝÀ¶ ¼±ÁøÈ¿¡ ±â¿©ÇÕ´Ï´Ù.
BONDWEB
º»µåÀ¥Plus
ÃֱٰԽù°
°æÁ¦Á¾ÇÕ´º½º
º¸µµÀÚ·á
½Ã°¡Æò°¡Ç¥
ÁÖ¿ä±Ý¸®
IRS/CRS
½ºÅ©·¦
ÇïÇÁµ¥½ºÅ©
´Ù¿î·Îµå¼¾ÅÍ
°øÁö»çÇ× & ´º½º
ÀÎÀçã±â
ENG
ÀÏÀÚ
ÆÄÀÏ
Á¦¸ñ
±â°ü¸í
01-26
[À¯Áø/ÇѺ´È]Àü±âÂ÷/¹èÅ͸®»ê¾÷ - K¹èÅ͸® ¼ÒÀç/ºÎǰ ÁÖ°¡ °¼¼..
À¯ÁøÅõÀÚÁõ±Ç
01-26
(¹Ì·¡¿¡¼ÂÁõ±Ç ±è¼®È¯) 2026³â 2¿ù ÁÖ¿ä °æÁ¦ÁöÇ¥ ¹× ÀÏÁ¤
¹Ì·¡¿¡¼Â´ë¿ì
01-26
(¹Ì·¡¿¡¼ÂÁõ±Ç ÀÌÁøÈ£) ½¶·³¹ö°Å (SLB US/Not Rated) : 4Q25 ¸®ºä..
¹Ì·¡¿¡¼Â´ë¿ì
01-26
(¹Ì·¡¿¡¼ÂÁõ±Ç À±ÀçÈ«) ÁÖ°£ ±Û·Î¹ú ETF ½ÃÀå µ¿Çâ : ±Û·Î¹ú ÁöÁ¤..
¹Ì·¡¿¡¼Â´ë¿ì
01-26
[½ÅÈï±¹ Àü·«] º£Æ®³² ÁßÀå±â Á¤Ã¥ ¹æÇ⼺:¹Î°£±â¾÷ ¹× ÀÎÇÁ¶ó
Çϳª±ÝÀ¶ÅõÀÚ
01-26
[KISÀÚ»êÆò°¡] 3»ç ½Å¿ëµî±Þ Á¾ÇÕÇ¥ (2026.01.26.)
KISÀÚ»êÆò°¡
01-26
[ÀÚµ¿Â÷] 2025³â ±Û·Î¹ú ÆÇ¸Å´Â ÆÒµ¥¹Í ÀÌÀü ¼öÁØ »óȸ
BNKÅõÀÚÁõ±Ç
01-26
[Çö´ëÂ÷Áõ±Ç ÇÏÀå±Ç] - [¿©Àǵµ ÇϽºÆÌ] ¶Ç ¼Ë´Ù¿î?
Çö´ëÂ÷Áõ±Ç
01-26
ÈÀåǰ µ¥Àϸ® ¾÷µ¥ÀÌÆ®: 1¿ù 23ÀÏ ±Ý¿äÀÏ Morning brief
»ï¼ºÁõ±Ç
01-26
[»ï¼º¿¡½ºµð¿¡½º (018260)] ¼ºÀå µ¿·Â ½ÇÀû ¹Ý¿µ±îÁö ½ÃÂ÷ Á¸Àç
»ï¼ºÁõ±Ç
01-26
[Samsung Biologics (207940)] Solid growth outweighing order ..
»ï¼ºÁõ±Ç
01-26
[Classys (214150)] Balancing core business growth with momen..
»ï¼ºÁõ±Ç
01-26
[Hanmi Pharmaceutical (128940)] Focus more on fundamentals t..
»ï¼ºÁõ±Ç
01-26
[1¿ù 4ÁÖ] Ķ¹Ú - ÁÖ°£ ¸ÅÅ©·Î/Å׸¶ ͏°´õ
»ï¼ºÁõ±Ç
01-26
[ÀÎÅÚ (NAS:INTC)] 4Q25 review - Beyond reason
»ï¼ºÁõ±Ç
Àüü : 407
óÀ½
ÀÌÀü
[11]
[12]
[13]
[14]
[15]
´ÙÀ½
³¡À¸·Î
Ȩ > ¸®¼Ä¡Á¤º¸ >
ÃֱٰԽù°